Immediate Impact
24 standout
Citing Papers
Medications for Obesity
2024 Standout
Targeting the incretin system in obesity and type 2 diabetes mellitus
2024 Standout
Works of Emily Day being referenced
Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Emily Day | 136 | 35 | 93 | 41 | 27 | 314 | |
| Malin R. Dollinger | 90 | 88 | 72 | 22 | 22 | 349 | |
| Maryam Kadivar | 90 | 114 | 96 | 49 | 37 | 322 | |
| John T. Cuttino | 54 | 40 | 70 | 28 | 28 | 297 | |
| Amedeo Vittorio Bedini | 206 | 64 | 58 | 24 | 27 | 337 | |
| Adnan Yöney | 103 | 60 | 81 | 27 | 34 | 337 | |
| Raghu Rajan | 101 | 90 | 97 | 32 | 20 | 360 | |
| N.K. Shukla | 110 | 130 | 131 | 26 | 34 | 312 | |
| Robert McLelland | 90 | 96 | 47 | 26 | 20 | 301 | |
| Émilie Marrer | 73 | 109 | 65 | 20 | 20 | 266 | |
| K. L. Parthasarathy | 116 | 103 | 74 | 29 | 22 | 343 |
All Works
Login with ORCID to disown or claim papers
Loading papers...